ArticleKidney international2018
Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
Erratum issuedOpen access · greenAbstract readMulticenter Study
In one paragraph
Article in Kidney international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 109 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 4 pooled it
11.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
109 citing papers in PubMed, 4 syntheses or guidelines pooled it, 195 citations in OpenAlex.
- Prediction models for progression from diabetic kidney disease to end-stage renal disease: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- [Recommendations for the Diagnosis and Treatment of Chronic Kidney Disease (CKD) by the Austrian Society of Nephrology].Wiener klinische Wochenschrift · 2025Guideline
- Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review.BMC medicine · 2024Pooled it
- Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis.Annals of internal medicine · 2020Pooled it
- Cardiorenal risk stratification in high-risk type 2 diabetes using a simple clinical score: findings from the ELIXA trial.Frontiers in endocrinology · 2026Trial
- Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025Trial
- Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids.Theranostics · 2020Trial
- Validation of the Standardized Outcomes in Nephrology-Life Participation Instrument in People with CKD.Kidney360 · 2026Article
- Kidney-Related Screening Indicator Trends in Korea: 2010-2024 (eGFR, 2012-2024) and 2025-2028 Forecasts Using National Health Insurance Service Health Screening Data.Medicina (Kaunas, Lithuania) · 2026Article
- Planning of kidney replacement therapy in advanced CKD using the KFRE formula in a Spanish multicenter cohort.Clinical kidney journal · 2026Article
- Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗.Kidney medicine · 2026Article
- Urinary angiotensinogen as a novel mortality predictor in diabetic kidney disease: a propensity-matched analysis from the KNOW-CKD.Clinical kidney journal · 2026Article
- The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026Observational
- Optimal patient care in advanced chronic kidney disease progressing to kidney failure.Nature reviews. Nephrology · 2026Review
- Development and Validation of a Multivariable Prediction Model for Kidney Failure in Early Autosomal Dominant Polycystic Kidney Disease.Journal of the American Society of Nephrology : JASN · 2026Article
- 10 tips on performing economic evaluation in kidney disease.Clinical kidney journal · 2026Review
- Developing an explainable machine learning model using body composition to predict cardiovascular mortality in initial dialysis patients: a multicenter study.Frontiers in physiology · 2026Article
- Prognostic Value of Claims Data for Chronic Kidney Disease-Associated Health Risks.Kidney & blood pressure research · 2026Article
- Chronic kidney disease progression rate and predictors in hypertensive patients: A 5-year retrospective follow-up study in Ethiopia.PloS one · 2026Article
- Article
49 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
22 authors at 16 institutions in 11 countries.
Morgan E GramsDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Yingying SangDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Shoshana H BallewDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Juan Jesus CarreroDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Ognjenka DjurdjevDepartment of Measurement and Reporting, Provincial Health Service Authority, Vancouver, British Columbia, Canada.
Hiddo J L HeerspinkDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, the Netherlands.
Kevin HoDepartment of Nephrology, Geisinger Medical Center, Danville, Pennsylvania, USA.
Sadayoshi ItoDivision of Nephrology, Endocrinology and Hypertension, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Angharad MarksInstitute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK.
David NaimarkSunnybrook Hospital, University of Toronto, Toronto, Ontario, Canada.
Danielle M NashInstitute for Clinical Evaluative Sciences, Ontario, Canada.
Sankar D NavaneethanSection of Nephrology, Baylor College of Medicine, Houston, Texas, USA.
Mark SarnakDivision of Nephrology at Tufts Medical Center, Boston, Massachusetts, USA.
Benedicte StengelINSERM UMR1018, CESP Center for Research in Epidemiology and Population Health, Team 5, Villejuif, France, UVSQ and UMRS 1018, Paris-Sud University, Villejuif, France.
Frank L J VisserenDepartment of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Angela Yee-Moon WangDepartment of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong.
Anna KöttgenDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg, Germany.
Andrew S LeveyDivision of Nephrology at Tufts Medical Center, Boston, Massachusetts, USA.
Mark WoodwardDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; The George Institute for Global Health, University of Oxford, Oxford, UK; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Kai-Uwe EckardtDepartment of Nephrology and Medical Intensive Care, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Brenda HemmelgarnCumming School of Medicine, Division of Nephrology, and Department of Community Health Sciences, University of Calgary, Alberta, Canada.
Josef CoreshDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Electronic address: ckdpc@jhmi.edu.
Johns Hopkins University · USTufts Medical Center · USBaylor College of Medicine · USCharité - Universitätsmedizin Berlin · DEGeisinger Medical Center · USInstitute for Clinical Evaluative Sciences · CAKarolinska Institutet · SEProvincial Health Services Authority · CAQueen Mary Hospital · CNTohoku University · JPUniversité Paris-Sud · FRUniversity Medical Center Groningen · NLUniversity Medical Center Utrecht · NLUniversity of Aberdeen · GBUniversity of Calgary · CAUniversity of Toronto · CA
Funding
ZOVIRAX CREAM TO TREAT HERPES LABIALIS IN ADOLESCENTSM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZELL, JASON · 1985 to 2010
$74.3MQAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7MScientific and Data Coordinating Center(SDCC) for the P*U01DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2001 to 2017
$50.1MInstitutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9MZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI NICHOLSON, WANDA K · 1985 to 2007
$37.3MStudy of the Care and Outcomes of REnal InsufficiencyU01DK060902 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2001 to 2025
$19.5MProspective Renal Insufficiency Cohort Evaluation:PRICEU01DK060984 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI COHEN, DEBBIE L · 2001 to 2025
$17.0MYQ MICRODELETIONS AND MALE INFERTILITYP20RR011145 · NCRR · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI SINHA-HIKIM, INDRANI · 1995 to 2009
$17.0MProspective Cohort Study of Chronic Renal InsufficiencyU01DK061028 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, PANDURANGA S · 2001 to 2025
$16.9MLimited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Hopkins Clinical CenterU01DK061022 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI APPEL, LAWRENCE JOHN · 2001 to 2025
$15.7MProposal for a Chicago-CRIC Clinical CenterU01DK060980 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LASH, JAMES P. · 2001 to 2025
$15.4MWARCEFP20RR011104 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI HIGGINBOTHAM, EVE J. · 1995 to 2009
$14.5MHSRD VA SDR 02-237NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR003098NCRR NIH HHS M01 RR000052NCRR NIH HHS M01 RR000827NCRR NIH HHS P20 RR011104NCRR NIH HHS P20 RR011145NHLBI NIH HHS HHSN268200900049CNIDDK NIH HHS K08 DK092287NIDDK NIH HHS K23 DK067303NIDDK NIH HHS K24 DK002818NIDDK NIH HHS R01 DK072231NIDDK NIH HHS R01 DK096920NIDDK NIH HHS R01 DK100446NIDDK NIH HHS R01 DK139225NIDDK NIH HHS U01 DK060902NIDDK NIH HHS U01 DK060963NIDDK NIH HHS U01 DK060980NIDDK NIH HHS U01 DK060984NIDDK NIH HHS U01 DK060990NIDDK NIH HHS U01 DK061022NIDDK NIH HHS U01 DK061028NIGMS NIH HHS P30 GM103337
Abstract
Patients with chronic kidney disease and severely decreased glomerular filtration rate (GFR) are at high risk for kidney failure, cardiovascular disease (CVD) and death. Accurate estimates of risk and timing of these clinical outcomes could guide patient counseling and therapy. Therefore, we developed models using data of 264,296 individuals in 30 countries participating in the international Chronic Kidney Disease Prognosis Consortium with estimated GFR (eGFR)s under 30 ml/min/1.73m
Indexed as
Decision Support TechniquesGlomerular Filtration RateAdultAgedCardiovascular DiseasesDisease ProgressionFemaleHumansKidneyMaleMarkov ChainsMiddle AgedMonte Carlo MethodPrognosisRenal InsufficiencyRenal Insufficiency, Chronicalbuminuriacardiovascular diseasechronic kidney disease
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.